About this trial
The objectives of this group project is to collect synovial fluid (SF) and paired sera and carry out preclinical studies to evaluate, alone or by combination testings, the potential of novel biomarkers for their prevalence and diagnostic/prognostic values in patients with arthritis, and to determine how therapeutic intervention regulate their levels.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Significant joint effusion
Disqualifiers
Hemorrhagic effusion
Traumatic effusion
Less than 3 ml total of collected fluid (used for routine analysis and culture)
Inability or refusal to consent
Trial population
patients suffering from various arthritides (rheumatoid arthritis, gout and other microcristalline arthritides, osteoarthritis, spondylarthropathies, juvenile idiopathic arthritis, and various other diseases, including inflammatory polyarthritis of recent-onset in adults
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Availability of paired synovial fluid and serum samples for exploratory studies
Availability of paired synovial fluid and serum samples, linked with anonymized clinical and treatment data, from patients suffering from various arthritides (rheumatoid arthritis, gout and other microcrystalline arthritides, osteoarthritis, spondylarthropathies, juvenile idiopathic arthritis, and various other diseases, including inflammatory polyarthritis of recent-onset in adults
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Gilles Boire
Lead sponsor
Université de Sherbrooke
Sponsor institution
Canadian Arthritis Network
Collaborator